Department of Chemistry, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Department of Biological Sciences, University of Southern California, 840 Downey Way, LJS 250, Los Angeles, CA, 90089, USA.
Chembiochem. 2018 Sep 17;19(18):1918-1921. doi: 10.1002/cbic.201800280. Epub 2018 Aug 10.
Metabolic chemical reporters (MCRs) of protein glycosylation are analogues of natural monosaccharides that bear reactive groups, like azides and alkynes. When they are added to living cells and organisms, these small molecules are biosynthetically transformed into nucleotide donor sugars and then used by glycosyltransferases to modify proteins. Subsequent installation of tags by bioorthogonal chemistries can then enable the visualization and enrichment of these glycoproteins. Although this two-step procedure is powerful, the use of MCRs has the potential to change the endogenous production of the natural repertoire of donor sugars. A major route for the generation of these glycosyltransferase substrates is the hexosamine biosynthetic pathway (HBP), which results in uridine diphosphate N-acetylglucosamine (UDP-GlcNAc). Interestingly, the rate-determining enzyme of the HBP, glutamine fructose-6-phosphate amidotransferase (GFAT), is feedback inhibited by UDP-GlcNAc. This raises the possibility that a build-up of UDP-MCRs would block the biosynthesis of UDP-GlcNAc, resulting in off target effects. Here, we directly test this possibility with recombinant human GFAT and a small panel of synthetic UDP-MCRs. We find that MCRs with larger substitutions at the N-acetyl position do not inhibit GFAT, whereas those with modifications of the 2- or 6-hydroxy group do. These results further illuminate the considerations that should be applied to the use of MCRs.
代谢化学糖基化蛋白报告物(MCRs)是天然单糖的类似物,带有反应基团,如叠氮化物和炔烃。当它们被添加到活细胞和生物体中时,这些小分子会被生物合成转化为核苷酸供体糖,然后被糖基转移酶用于修饰蛋白质。随后通过生物正交化学方法安装标签,然后可以可视化和富集这些糖蛋白。虽然这两步程序很强大,但 MCRs 的使用有可能改变天然供体糖库的内源性产生。这些糖基转移酶底物的主要生成途径是己糖胺生物合成途径(HBP),导致尿苷二磷酸 N-乙酰葡萄糖胺(UDP-GlcNAc)。有趣的是,HBP 的限速酶谷氨酰胺果糖-6-磷酸酰胺转移酶(GFAT)被 UDP-GlcNAc 反馈抑制。这就提出了这样一种可能性,即 UDP-MCRs 的积累会阻止 UDP-GlcNAc 的生物合成,从而导致非靶向效应。在这里,我们使用重组人 GFAT 和一小部分合成 UDP-MCR 直接测试了这种可能性。我们发现,在 N-乙酰位置具有较大取代的 MCR 不会抑制 GFAT,而那些具有 2-或 6-羟基修饰的 MCR 则会抑制 GFAT。这些结果进一步阐明了在使用 MCRs 时应考虑的因素。